We are live on
!
Find out more
CFO
Callan Family Office Portfolio holdings
AUM
$4.41B
1-Year Est. Return
26.21%
This Fund
S&P 500
This Quarter
Est. Return
+4.14%
1 Year Est. Return
+26.21%
3 Year Est. Return
+68.96%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.65B
AUM Growth
+$1.52B
(+48%)
Cap. Flow
+$1.42B
Cap. Flow
% of AUM
30.5%
Top 10 Holdings %
Top 10 Hldgs %
26.25%
Holding
1,130
New
282
Increased
733
Reduced
76
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$109M |
| 2 |
Vanguard Russell 3000 ETF
VTHR
|
+$68.2M |
| 3 |
NVIDIA
NVDA
|
+$43.4M |
| 4 |
Microsoft
MSFT
|
+$35.4M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$31.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$3.75M |
| 2 |
Charter Communications
CHTR
|
+$2.66M |
| 3 |
Comcast
CMCSA
|
+$2.58M |
| 4 |
International Flavors & Fragrances
IFF
|
+$2.18M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$1.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.93% |
| 2 | Financials | 13.36% |
| 3 | Healthcare | 9.15% |
| 4 | Industrials | 7.57% |
| 5 | Consumer Discretionary | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
SES AI
SES
$208M
| $110K | ﹤0.01% |
61,016
+29,741
| +95% | +$66.7K |
|
1077
NIO
NIO
$11.9B
| $101K | ﹤0.01% |
+19,742
| New | +$122K |
|
|
CMBT
1078
CMB.TECH NV
CMBT
$4.73B
| $99.5K | ﹤0.01% |
+10,316
| New | +$100K |
|
1079
Wendy's
WEN
$1.46B
| $92.4K | ﹤0.01% |
+11,088
| New | +$95.7K |
|
1080
MaxCyte
MXCT
$126M
| $85.4K | ﹤0.01% |
+55,122
| New | +$88K |
|
1081
Opendoor
OPEN
$3.38B
| $84.8K | ﹤0.01% |
14,541
+2,324
| +19% | +$16.7K |
|
1082
ADC Therapeutics
ADCT
$144M
| $84.2K | ﹤0.01% |
+23,842
| New | +$96.7K |
|
1083
Plug Power
PLUG
$3.04B
| $80.8K | ﹤0.01% |
40,997
+10,201
| +33% | +$26.6K |
|
|
TE
1084
T1 Energy
TE
$1.63B
| $79.6K | ﹤0.01% |
11,922
+1,634
| +16% | +$7.21K |
|
|
MPT
1085
Medical Properties Trust
MPT
$2.81B
| $75.5K | ﹤0.01% |
+15,094
| New | +$78.6K |
|
1086
Sana Biotechnology
SANA
$980M
| $65.3K | ﹤0.01% |
+16,032
| New | +$71.8K |
|
1087
SEACOR Marine Holdings
SMHI
$258M
| $62K | ﹤0.01% |
+10,307
| New | +$68.1K |
|
1088
C4 Therapeutics
CCCC
$412M
| $60.6K | ﹤0.01% |
+31,743
| New | +$75.2K |
|
1089
Nautilus Biotechnolgy
NAUT
$115M
| $50.6K | ﹤0.01% |
25,970
+11,140
| +75% | +$18.3K |
|
1090
Cabaletta Bio
CABA
$455M
| $49.4K | ﹤0.01% |
+22,575
| New | +$55.9K |
|
|
ACRE
1091
Ares Commercial Real Estate
ACRE
$270M
| $49.4K | ﹤0.01% |
+10,335
| New | +$50.2K |
|
1092
Lightwave Logic
LWLG
$1.25B
| $48.7K | ﹤0.01% |
15,024
+1,741
| +13% | +$7.73K |
|
1093
Maravai LifeSciences
MRVI
$919M
| $47.1K | ﹤0.01% |
14,485
+4,230
| +41% | +$14.2K |
|
1094
Wipro
WIT
$20B
| $44.7K | ﹤0.01% |
15,732
+5,140
| +49% | +$14K |
|
1095
Holley
HLLY
$384M
| $43.8K | ﹤0.01% |
+10,596
| New | +$38.2K |
|
1096
Solid Power
SLDP
$532M
| $43.3K | ﹤0.01% |
10,199
| – | – |
|
1097
Prime Medicine
PRME
$559M
| $39.2K | ﹤0.01% |
+11,292
| New | +$50.2K |
|
1098
Bit Digital
BTBT
$482M
| $38.5K | ﹤0.01% |
+20,345
| New | +$58.8K |
|
1099
Tenaya Therapeutics
TNYA
$163M
| $35.6K | ﹤0.01% |
50,061
+13,792
| +38% | +$18.8K |
|
1100
Editas Medicine
EDIT
$442M
| $32.5K | ﹤0.01% |
+15,832
| New | +$45.7K |
|
Similar funds
FIS
CAU
EQF
SFM
EC
IC
GIBU
Callan Family Office's Q4 2025 Portfolio in Review
As of Q4 2025, Callan Family Office held 1,130 positions worth $4.65B, up 48% from $3.14B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Callan Family Office deployed $1.42B of net new capital in Q4 2025, opening 282 new positions and adding to 733 existing holdings. Its largest new stake was Vanguard Russell 3000 ETF: 228,815 shares worth $68.7M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Fiserv Inc, an estimated $3.75M trimmed.
- Callan Family Office's largest Q4 2025 buy was Vanguard Russell 3000 ETF: 228,815 shares worth $68.7M.
- Callan Family Office added most to Vanguard S&P 500 ETF in Q4 2025, an estimated $109M increase.
- Callan Family Office's biggest Q4 2025 reduction was Fiserv Inc, cutting an estimated $3.75M.
- Callan Family Office fully exited HubSpot in Q4 2025, selling an estimated $1.16M.
- Callan Family Office's ten largest holdings make up 26% of its $4.65B portfolio in Q4 2025.
- Callan Family Office opened 282 new positions and closed 19 in Q4 2025.
- Callan Family Office's portfolio value rose 48% quarter-over-quarter to $4.65B.
Based on Callan Family Office's 13F filing for Q4 2025, filed 12 Feb 2026.